This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Grunenthal Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Philip Skone
Introduction
Philip Skone is an accomplished inventor based in Herts, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as voltage-gated calcium channel blockers. His work is vital in the treatment and prevention of pain and various diseases.
Latest Patents
Philip Skone holds a patent for "Fluoromethyl-substituted pyrrole carboxamides." This invention relates to pyrrole carboxamides that bear a fluoromethyl moiety, which are utilized as voltage-gated calcium channel blockers. The patent also covers pharmaceutical compositions containing these compounds, highlighting their potential use in treating and preventing pain and other disorders.
Career Highlights
Philip Skone is currently employed at Grünenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work at Grünenthal has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Philip has collaborated with notable colleagues, including Stefan Schunk and Melanie Reich. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.
Conclusion
Philip Skone's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to impact the treatment of pain and various disorders, showcasing the significance of his research in the medical community.